SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

04 Aug 2022 Evaluate
The company witnessed a 10.80% growth in the revenue at Rs. 4930.08 millions for the quarter ended June 2022 as compared to Rs. 4449.62 millions during the year-ago period.A slender decline of -27.06% was recorded to Rs. 730.19  millions from Rs. 1001.09 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 994.18 millions from 1374.76 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 4930.08 4449.62 10.80 4930.08 4449.62 10.80 15189.65 13254.49 14.60
Other Income 193.99 234.34 -17.22 193.99 234.34 -17.22 787.34 971.46 -18.95
PBIDT 994.18 1374.76 -27.68 994.18 1374.76 -27.68 3255.80 4214.76 -22.75
Interest 6.96 8.00 -13.00 6.96 8.00 -13.00 30.48 34.02 -10.41
PBDT 987.22 1366.76 -27.77 987.22 1366.76 -27.77 3225.32 4180.74 -22.85
Depreciation 93.17 94.95 -1.87 93.17 94.95 -1.87 370.81 376.23 -1.44
PBT 894.05 1271.81 -29.70 894.05 1271.81 -29.70 2854.51 3804.51 -24.97
TAX 163.86 270.72 -39.47 163.86 270.72 -39.47 658.15 859.61 -23.44
Deferred Tax -79.14 -40.28 96.47 -79.14 -40.28 96.47 -21.85 14.45 -251.21
PAT 730.19 1001.09 -27.06 730.19 1001.09 -27.06 2196.36 2944.90 -25.42
Equity 165.91 168.81 -1.72 165.91 168.81 -1.72 168.81 168.81 0.00
PBIDTM(%) 20.17 30.90 -34.73 20.17 30.90 -34.73 21.43 31.80 -32.59

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×